Nonetheless, due to MATT’s low cytotoxicity against cancer cells (Supplementary Fig. S1), its antitumor activity, even when efficiently delivered to the tumor, is modest compared with that of a robust cytotoxic agent such as paclitaxel.30 Here, TMEM79 is linked to neoplasm.